Cargando…

Age but not sex may explain the negative effect of arterial hypertension and diabetes on COVID-19 prognosis

Detalles Bibliográficos
Autores principales:	Pirola, Carlos J, Sookoian, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212962/ https://www.ncbi.nlm.nih.gov/pubmed/32407757 http://dx.doi.org/10.1016/j.jinf.2020.05.010

Ejemplares similares

Telomere length in the two extremes of abnormal fetal growth and the programming effect of maternal arterial hypertension
por: Tellechea, Mariana, et al.
Publicado: (2015)

COVID-19 and ACE2 in the Liver and Gastrointestinal Tract: Putative Biological Explanations of Sexual Dimorphism
por: Pirola, Carlos J., et al.
Publicado: (2020)

Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis
por: Pirola, Carlos J., et al.
Publicado: (2020)

Systems Biology Elucidates Common Pathogenic Mechanisms between Nonalcoholic and Alcoholic-Fatty Liver Disease
por: Sookoian, Silvia, et al.
Publicado: (2013)

Meta-analysis of the influence of TM6SF2 E167K variant on Plasma Concentration of Aminotransferases across different Populations and Diverse Liver Phenotypes
por: Sookoian, Silvia, et al.
Publicado: (2016)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Genetic predisposition in nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Repurposing drugs to target nonalcoholic steatohepatitis
por: Sookoian, Silvia, et al.
Publicado: (2019)

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology
por: Sookoian, Silvia, et al.
Publicado: (2020)

The lipidome in nonalcoholic fatty liver disease: actionable targets
por: Pirola, Carlos J., et al.
Publicado: (2021)

Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
por: Pirola, Carlos J., et al.
Publicado: (2022)

Personalized medicine in nonalcoholic fatty liver disease
por: Pirola, Carlos J., et al.
Publicado: (2022)

SARS-CoV-2 targets the liver and manipulates glucose metabolism
por: Pirola, Carlos J., et al.
Publicado: (2023)

Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
por: Sookoian, Silvia, et al.
Publicado: (2023)

Metabolomics by magnetic resonance spectroscopy may not sufficiently explain “brain fog” in neuro-COVID
por: Finsterer, Josef
Publicado: (2022)

Importance of Primary Healthcare in prognosis of individuals with diabetes mellitus and/or hypertension
por: de Paiva, Aline Rodrigues
Publicado: (2021)

Pleiotropy within gene variants associated with nonalcoholic fatty liver disease and traits of the hematopoietic system
por: Pirola, Carlos Jose, et al.
Publicado: (2021)

Increased number of positive coagulase-negative staphylococci in blood cultures is partly explained by increased use of intra-arterial catheters in patients with COVID-19
por: Yusuf, E., et al.
Publicado: (2021)

The Protection Conferred by HSD17B13 rs72613567 Polymorphism on Risk of Steatohepatitis and Fibrosis May Be Limited to Selected Subgroups of Patients With NAFLD
por: Vilar-Gomez, Eduardo, et al.
Publicado: (2021)

Immunity‐modulated sex disparity on COVID‐19 prognosis
por: Liu, Dan, et al.
Publicado: (2020)

An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al
por: Zahl, P-H
Publicado: (2005)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Single cell gene expression profiling of nasal ciliated cells reveals distinctive biological processes related to epigenetic mechanisms in patients with severe COVID-19()
por: Diambra, Luis, et al.
Publicado: (2022)

Vitamin D binding protein and its polymorphisms may explain the link between vitamin D deficiency and COVID-19
por: Speeckaert, Marijn M., et al.
Publicado: (2021)

Mean Age of First Sex: Do They Know What We Mean?
por: de Irala, Jokin, et al.
Publicado: (2011)

Reply: An inverse association between tumour size and overdiagnosis may explain the results by Bucchi et al
por: Bucchi, L, et al.
Publicado: (2005)

Gut Microbiota-Derived Propionate Production May Explain Beneficial Effects of Intermittent Fasting in Experimental Colitis
por: Su, Junhong, et al.
Publicado: (2020)

Sex disparities in thyroid cancer may need further exploration
por: Zhou, Jun
Publicado: (2023)

Deficiency of HTR4 and ADRB1 caused by SARS-CoV-2 spike may partially explain multiple COVID-19 related syndromes including depression, cognitive impairment, loss of appetite, heart failure, and hypertension
por: Lv, Lu, et al.
Publicado: (2022)

Mothers of children with food allergies report poorer perceived life status which may be explained by limited career choices
por: Frykas, Tara Lynn Mary, et al.
Publicado: (2021)

Prevalence of Arterial Hypertension in Cirrhosis of Liver
por: Prabhu P., Rajesh, et al.
Publicado: (2009)

The impact of sex disparities on the clinical behavior and prognosis of thyroid cancer
por: Wang, Wenlong
Publicado: (2023)

Binswanger disease may benefit from omental arteries
por: Goldsmith, Harry S.
Publicado: (2015)

Putative mechanisms explaining neuro-COVID
por: Finsterer, Josef
Publicado: (2021)

No change in small low‐density lipoprotein cholesterol levels with pemafibrate might explain the negative results of the PROMINENT trial
por: Hirano, Tsutomu
Publicado: (2023)

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
por: Sasaki, Hironobu, et al.
Publicado: (2022)

Pulmonary hypertension may be secondary in carriers of compound heterozygous FOXRED1 variants
por: Finsterer, Josef
Publicado: (2019)

COVID-19 subgroups may slow down biological age acceleration
por: Guo, Yu, et al.
Publicado: (2023)

Management of hospitalized patients with pulmonary arterial hypertension and COVID-19 infection
por: Sahay, Sandeep, et al.
Publicado: (2020)

Overdue to understand anticoagulation in pulmonary arterial hypertension
por: Parikh, Kishan S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_i5nut19o9hlphgbi6icjp2d672